Popular weight-loss drugs like Ozempic and Zepbound have revolutionized how we tackle obesity. But now, emerging reports ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

A report from the human resources trade group SHRM, which just released its 2025 Benefits Survey—the most comprehensive ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.